Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2011-3-16
pubmed:abstractText
CD160 is expressed by human and mouse natural killer (NK) cells and other cytotoxic lymphocyte subpopulations. CD160 is mostly expressed as a trimeric 83 kDa glycosylphosphatidylinositol (GPI)-anchored activating NK receptor, cleaved upon IL-15 stimulation in a secreted trimeric soluble form (sCD160) that binds to major histocompatibility complex (MHC) class I molecules, while a transmembrane isoform appears. sCD160 exhibits immunoregulatory function as it inhibits CD8(+) T-lymphocyte cytotoxic activity. We show that human mast cells (MCs) express CD160. In human and mouse skin, resident MCs expressed CD160, whereas in C57BL/6-Kit(W-sh/W-sh) mice, CD160(+) cells were only identified at the site of reconstitution with syngeneic cultured MCs. In the human mast cell line, HMC-1, we only identified the transcripts of the GPI-anchored CD160 isoform. Furthermore, CD160 was identified in HMC-1 and mouse MC supernatants, suggesting that MCs release sCD160. Supporting this hypothesis, HMC-1 express the GPI-specific phospholipase D variant 2 involved in the NK lymphocyte membrane cleavage of CD160, and morphological studies highlighted a relative loss of CD160 expression in inflammatory skin sites, where MC degranulation is expected to occur. We also demonstrated an inhibition of T-cell cytotoxicity by HMC-1 supernatant that was partially reversed by anti-CD160 mAb. In conclusion, sCD160, produced by MCs, may have a role in T-cell-MC interactions in vivo.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1523-1747
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
131
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
916-24
pubmed:meshHeading
pubmed-meshheading:21191401-Animals, pubmed-meshheading:21191401-Antibodies, Monoclonal, pubmed-meshheading:21191401-Antigens, CD, pubmed-meshheading:21191401-COS Cells, pubmed-meshheading:21191401-Cell Communication, pubmed-meshheading:21191401-Cercopithecus aethiops, pubmed-meshheading:21191401-Culture Media, Conditioned, pubmed-meshheading:21191401-Dermatitis, pubmed-meshheading:21191401-Dermis, pubmed-meshheading:21191401-Female, pubmed-meshheading:21191401-GPI-Linked Proteins, pubmed-meshheading:21191401-Gene Expression, pubmed-meshheading:21191401-Humans, pubmed-meshheading:21191401-Jurkat Cells, pubmed-meshheading:21191401-Killer Cells, Natural, pubmed-meshheading:21191401-Mast Cells, pubmed-meshheading:21191401-Mice, pubmed-meshheading:21191401-Mice, Inbred C57BL, pubmed-meshheading:21191401-Mice, Nude, pubmed-meshheading:21191401-RNA, Messenger, pubmed-meshheading:21191401-Receptors, Immunologic, pubmed-meshheading:21191401-Solubility
pubmed:year
2011
pubmed:articleTitle
Human and mouse mast cells express and secrete the GPI-anchored isoform of CD160.
pubmed:affiliation
AP-HP, Groupe Hospitalier Henri Mondor-Albert Chenevier, Department of Pathology, and Université Paris 12, Faculté de Médecine, Créteil, France. nicolas.ortonne@hmn.aphp.fr
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't